9 December 2020 in Addiction Research & Theory
People who use drugs understand drugs and drug use in ways that are often different to the way knowledge of drug use is constructed within the dominant medico-legal discourse. Their experiences are, more often than not, represented in negative ways within dominant discourse, a disconnect that can create adverse consequences for people who use drugs, through the production of stigma and shame leading to poor health and social outcomes. A key difference in how drugs are understood by people who use drugs is the capacity of the former to recognize positive aspects of drug use and create more agentic subjectivities for themselves concerning the use of drugs. Using a thematic analysis of the online forum Australian Drug Discussion, hosted by Bluelight.org, we identify positive drug stories and the contexts of their emergence, as subversions or modifications of dominant understandings. We argue that positive understandings of drug use, as well as recognition of the way their expression serves to generate agency for people who use drugs within or against the confines of dominant discourse, may provide opportunities to limit further the harms flowing from stigmatization and negativity.
29 August 2022 in Contemporary Drug Problems
Background: There is limited research on the provision of harm reduction services to people who use psychedelics. Little is known about provision of care to people consuming psychedelics outside of clinical trials. Methods: We investigated how people who used psychedelics discussed their preferences for care (or “trip sitting”) on two online forums: The Shroomery and DMT Nexus. A thematic analysis of the discussion was conducted to better understand consumer preferences for harm reduction services and resources. Results: We identified two key themes: experience and remote sitting. Forum participants valued trip sitters who had experienced psychedelic and other non-ordinary states of consciousness, who had knowledge of the health and medical industry, psychedelic literature and/or had previously cared for other psychedelic consumers. Forum participants also identified the value of consuming a psychedelic without somebody who was in their physical proximity, through communicating their plans to a remote trip sitter. The use of online tools was identified as a way to maximize the benefit of privacy while retaining carer benefits. Conclusion: Demand for trip sitters with lived psychedelic experience is likely influenced by stigma and empathy. Trip sitters who could relate to the effects of psychedelics assisted consumers in avoiding stigma while vulnerable under the effects of psychedelics. As such, psychedelic harm reduction services should be delivered by peers to ensure care maximizes the benefits of empathy. Psychedelic harm reduction services should consider how remote workers could be employed. There is a clear demand for remote psychedelic care services and to our knowledge this has not yet been explored.
15 January 2021 in Journal of Evolutionary Psychology
There is increasing evidence that psychedelic-assisted psychotherapy is effective for a range of psychological conditions. There are likely numerous mechanisms of action that contribute to these clinical effects. One such mechanism of action might involve psychedelics increasing levels of empathic functioning. This paper synthesises research concerning the relationship between psychedelics and empathy, emphasising neuroscientific and clinical contexts. We conclude that neuropsychological and clinical evidence imply psychedelics could lead to increased empathic functioning. The effects of psychedelics on the 5-HT system, default mode network, neural connectivity and ego dissolution are implicated in these changes. Changes in empathic functioning also likely relate to increases in the personality trait of openness associated with psychedelic drug use, which is well documented. Increased empathic function likely has clinical implications, leading to increased social connectedness as well as prosocial attitudes and behaviours more broadly.
28 September 2023 in Journal of Psychedelic Studies
Background and Aims: Both Peyote and San Pedro cacti contain mescaline, a classical psychedelic eliciting mystical and visual effects, but only Peyote is a vulnerable species. We sought to address the questions 1; do people who use Peyote substitute with San Pedro, and vice versa, and; 2. how popular is the use of wild harvested mescaline cactus compared with the use of cultivated plants?Methods: Data were collected as part of the 2022 Global Drug Survey, a self-report survey distributed internationally in 11 languages. We asked mescaline cacti consumers about consumption practices, preferences and conservation and conducted chi square tests of associations comparing all motivations by preferred mescaline source.Results: Of participants who reported using mescaline in the last 12 months (N = 284; 73.2% male, 21.8% female, 5.0% other gender; mean age 36.3, SD 12.5), 20.0% reported consuming Peyote collected from native habitats. Of participants specifying Peyote as their preferred source of mescaline, 82.2% had consumed Peyote in the past 12 months. Indigenous cultural traditions (57.8%), availability (40.0%) and environmental sustainability (33.3%) were the most commonly reported motivations for Peyote preference (n = 45), whereas for San Pedro (n = 86), availability (54.7%), potency (45.3%) and indigenous cultural traditions (44.2%) were most the commonly reported San Pedro preference motivations. Price and potency were significantly more likely to be chosen by those preferring San Pedro compared with Peyote. Less than 7% of participants who consumed San Pedro in the past 12 months had consumed San Pedro from native habitats. Of the participants who specified San Pedro as their preferred source of mescaline, 96.5% had consumed San Pedro in past 12 months. San Pedro was the most commonly reported source of mescaline product consumed (56.1%) with Trichocereus bridgesii being the most reported preferred San Pedro species. Mescaline cacti consumed in the last 12 months rarely deviated from mescaline cacti of preference.Conclusions: Wild Peyote is not the most popular mescaline source, but consumption of related products remains unsustainable. Promoting San Pedro as a Peyote substitute may act as an intervention to reduce Peyote consumption.
6 May 2022 in Addiction Research & Theory
Contemporary clinical research into the psychotherapeutic administration of psychedelics has primarily emphasized the importance of therapeutic interpersonal interactions to assist clients prepare for and integrate the acute effects of psychedelics. Alternative therapeutic frameworks have encouraged active talk therapy between therapists and clients during the administration phase. We used data gathered from forums to investigate consumer preferences concerning interpersonal interactions during their psychedelic-occasioned experience. Google was used to locate relevant posts on the psychedelic forums The Shroomery and The DMT Nexus. We analyzed these posts using thematic analysis, in which two researchers independently categorized posts in accordance with emergent themes. These themes were then refined through iterative reflexivity. We then identified four themes pertaining to psychedelic consumer interpersonal interaction preferences: nonintrusive; boundary setting; help; and sober sitter or coconsumer. Further analysis revealed parallels between consumer preferences and clinical guidelines for psychedelic-assisted psychotherapy, including the emphasis of carer acceptance; minimal involvement; nondirection; hazard management and emotional stability. However, there was also disparity between consumer preferences and guidelines, specifically concerning desires for consumer agency; for psychedelic consumption alongside other consumers, and for carers who had consumed psychedelics themselves. These findings have clinical implications and thus may aid the development of future guidelines.